US Stock MarketDetailed Quotes

ELVN Enliven Therapeutics

Watchlist
  • 25.410
  • -0.020-0.08%
Close Nov 21 16:00 ET
  • 26.400
  • +0.990+3.90%
Post 20:01 ET
1.24BMarket Cap-14093P/E (TTM)

Enliven Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Enliven Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Enliven Therapeutics Earnings Reports

  • Enliven Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 13 16:20 ET

  • Enliven Therapeutics | 8-K: Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update

    Nov 13 16:16 ET

  • Enliven Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 13 16:19 ET

  • Enliven Therapeutics | 8-K: Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update

    Aug 13 16:14 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 15, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data